Bunion Surgery Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034

Bunion is also known as Hallux Valgus, is referred to the bony bump which develops over time inside the foot at the toe joint. The bunion surgery involves the removal or fixation of the bony growth, improving the walking and alignment of the foot.                

MARKET OVERVIEW 

The market valuation of the bunion surgery market was valued at approximately USD xx billion in 2023 and is projected to reach USD xx billion in 2034 exhibiting a CAGR of xx.x% during the forecast period of 2024-2034. The market is aligned with healthcare sector, which makes it a sustainable and growing market. 

GROWTH DRIVERS 

The rise in the incidents of foot deformities is one of the significant drivers of the market, driving the demand for bunion surgical solutions. As per National Institute of Health (NIH), this deformity is a relatively common condition and occurs in approximately 23% of adults aged 18 to 65 years and up 36% of adults older than 65 years. When looking at adult females, this deformity occurs as high as 30%.

The prevalence is higher in those who wear shoes or heels when compared to the barefoot population, creating significant opportunities of the market. The rise in aging population is another significant driver of the market as they are more incident to these conditions as per NIH data. WHO (World Health Organization) states that it is estimated that 1 in 6 people in the world will be aged 60 years or over, by 2030.

Currently, the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion), driving the demand of the market. Moreover, the patients shift towards minimally invasive procedures drives the market demand due to faster recovery and reduced pain, driving the demand of the market.  

MARKET SEGMENTATION: 

·         By Surgery Type- minimally invasive surgery and traditional surgery  

·         By Product Type- implant and fixation devices and surgical instruments 

·         By Patient Type- adult and pediatric 

·         By Distribution Channel- direct sales, distributors and retailers and online sales 

·         By End Users- hospitals, ambulatory surgical centers and orthopedic clinics 

·         By Regions- North America, Europe, Asia Pacific, South America, Middle East and Africa

Bunion Surgery Market Segment by Surgery Type Review: 

In the minimally invasive surgery, the surgeons removes the bunions with the help of tiny incisions, enabling faster recovery and patient’s overall wellbeing. Whereas, the traditional surgery is referred to the conventional surgery which includes larger incisions for the extraction of the bunion but it takes longer duration for the recovery. 

Bunion Surgery Market Segment by Product Type Review: 

In the bunion surgery market, the implants and fixation devices are referred to the devices such as screws, plates or pins that are used to stabilize the integrity of the bone structure which enables proper alignment. The surgical instruments are referred to the instruments that are utilized in the surgical procedure while removal of the bunion such as cutting, drilling and shaping.             
 
Regional Analysis: 

North America is a significant market driven by the presence of key global players and well-established and advance healthcare ecosystem. Europe is another significant market driven by the presence of key global companies and robust healthcare facilities. APAC is a significantly growing market driven by expansion of healthcare sector driving the accessibility of the market. MEA is a promising market driven by investments in healthcare infrastructure. South America is another growing market driven by rise in the prevalence of bunions and improving healthcare sector.      

Key Challenges: 

The bunion surgery market involves significant upfront investment for advanced surgery techniques like minimally invasive procedures, may hinder the market growth due to financial constraints. Moreover, the market faces competition from non-surgical alternatives like orthotics or splints which doesn’t require any surgical intervention, hinder the market adoption.     

         
Competitive Landscape: 

In the highly competitive bunion surgery market, companies are investing heavily in research and development to innovate and improve their products and services. They are also collaborating, forming strategic partnerships, or acquiring other companies to gain access to new market segments, enhance distribution networks, and increase market share.

The key recent news and development includes-

·         In August 2024, Ankle & Foot Centers of America introduced advanced, minimally invasive bunion surgery that aims to set new standards in foot care and patient recovery.

·         In February 2024, Paragon 28, Inc. launched the PRECISION MIS Bunion System, a minimally invasive surgical technique that enables surgeons to perform distal metatarsal osteotomies.

·         In July 2024, Stryker (US) acquired Artelon Inc. (Georgia), a company specializing in innovative soft tissue fixation products for foot and ankle, as well as sports medicine procedures. This acquisition enhances the soft tissue fixation portfolio of Stryker.

·         In May 2023, Medartis AG (Switzerland) acquired Nextremity Solutions, Inc. (US). The deal will help accelerate and scale its ongoing expansion activities in the US market, which is regarded as one of the major growth drivers for extremities business in the country.

·         In August 2025, Johnson & Johnson Services, Inc. (US) introduced the TriLEAP Lower Extremity Anatomic Plating System through its subsidiary DePuy Synthes (US). It is used for bunionectomies, osteotomies, fusions, and foot or ankle fractures.

·         In February 2022, Johnson & Johnson Services Inc. (US) acquired CrossRoads Extremity Systems (US), which focuses on procedure-specific, sterile-packed foot and ankle implants and instruments.  
 
Global Key Players:  

·         Stryker

·         Johnson and Johnson

·         CONMED Corporation

·         Zimmer Biomet

·        Smith & Nephew

·         Medartis AG

·         Enovis Corporation

·         BioPro, Inc.

·         Invamed

·         Paragon 28, Inc.

·         Other Players